\
&
Contact us
\
&
Contact us
Published on | 2 years ago
ProgrammesNCP Flanders is conducting a short survey to collect feedback on its services and suggestions on how they can be further improved.
The NCP Flanders team greatly appreciates it if you could take a few minutes of your time (if you haven’t done so yet) to provide your answers and suggestions via this link.
The survey will be open for answers for another 2,5 weeks until 13 October 2023.
The survey is anonymous and structured along three main chapters: NCP assistance, info sessions, and NCP website & LinkedIn. If the responding person indicates not to know one of these aspects, the survey will automatically continue with the next chapter.
Thank you very much for your highly appreciated feedback!
Your NCP Flanders Team
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
AI Continent Deployment: Best use of technologies
The LDT4SSC (Local Digital Twins for Smart and Sustainable Communities) project has opened a new cascade funding call to local network of cities, regions, and digital innovators. This call supports co-funding for three Work Strands with a minimum available budget of 10.8 Million euros: - Work strand 1 - interconnecting existing LDTs: At least... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
